Effect of glucagon-like peptide-1 receptor agonists on adipokine level of nonalcoholic fatty liver disease in rats fed high-fat diet

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is the leading cause of liver disease worldwide, and no effective treatment exists until now. Glucagon-like peptide-1 receptor agonists are becoming the preferred therapeutic option for the management of obesity and are becoming the preferred trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Miaomiao, Niu, Xiaohong, Liu, Yan, Zhang, Dong, Yuan, Danni, Shen, Huimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712363/
https://www.ncbi.nlm.nih.gov/pubmed/33336025
http://dx.doi.org/10.1515/med-2020-0212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712363/
https://www.ncbi.nlm.nih.gov/pubmed/33336025
http://dx.doi.org/10.1515/med-2020-0212

Ejemplares similares